Michele Tafoya, the Republican nominee for Minnesota’s open U.S. Senate seat, has claimed Minnesotans are too embarrassed to admit where they live when travelling out of state. The former sportscaster, who previously
More
Despite rising costs driven partly by AI investment, the large law firm sector is posting another year of robust financial performance across key metrics. New findings from the Citi Global Wealth at
More
The FTSE 100 is expected to edge higher at the open on Thursday, with spread betters forecasting a gain of around 9 points for the index. The tentative optimism follows an overnight
More
Equity markets ended the session in mixed fashion, with declining bond yields offering some relief while a significant selloff in semiconductor stocks weighed heavily on major indices. The technology sector bore the
More
President Donald Trump renewed his public assault on Federal Reserve interest rate policy on Wednesday, insisting solid economic data should not prevent the central bank from cutting rates. Trump accused Fed officials
More
The FTSE 250 index has reached record high territory, with technical analysts pointing to a healthy volume pattern as confirmation of the bullish move. Volume patterns are closely watched by technical analysts
More
The grey squirrel warning that did the rounds in December 2025 read, at the time, like one of those seasonal filler stories that pop up every winter — a pest control company
More
The London Underground has never been celebrated for its pleasant aromas, but a new scientific study has finally ranked every line by how badly it smells. Natural deodorant brand Fussy, known from
More
CDMO SK Pharmteco has completed two advanced manufacturing facilities at its production campus in Swords, Ireland, significantly expanding its pharmaceutical ingredient capabilities. The company first announced plans for a phased expansion at
More
SK Biopharmaceuticals has struck its first-ever settlement with a generic drug manufacturer seeking to produce a copycat version of its epilepsy treatment Xcopri (cenobamate). The agreement is with India’s MSN Laboratories, which
More